NXGL
NEXGEL, INC.
NEXGEL, INC. (NXGL) has 4 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 23, 2026.
The most active filer is Chief Executive Officer Levy Adam R. with 8 filings.
- Industry:Medical - Instruments & Supplies
- CEO:Adam R. Levy
- Employees:19
- HQ:Langhorne, PA, US
- IPO:2021-12-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$19K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$4.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 6,000 | $4K | Jun 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 5,000 | $3K | Jun 23 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,000 | $2K | Jun 9 | SEC ↗ | |
| Chief Executive Officer | Sale | 2,000 | $1K | Jun 3 | SEC ↗ | |
Levy Adam R.First filing | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | SEC ↗ |
Levy Adam R.First filing | Chief Executive Officer | Sale | 7,000 | $4K | May 30 | SEC ↗ |
Levy Adam R.First filing | Chief Executive Officer | Sale | 3,000 | $2K | May 30 | SEC ↗ |
Related companies
NEXGEL, INC. is in the Healthcare sector.